|
"whang peng j"的相關文件
顯示項目 101-125 / 215 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2009-05-20 |
Phase II randomized trial of erlotinib versus vinorelbine in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) aged >= 70 years in Taiwan
|
Chen, Y;Tsai, C;Shih, J;Perng, R;Whang-Peng, J |
| 國家衛生研究院 |
2008-08 |
A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly
|
Chen, YM;Perng, RP;Shih, JF;Whang-Peng, J |
| 國家衛生研究院 |
2008-07 |
Diagnostic and therapeutic evaluation of In-111-vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model
|
Chow, TH; Lin, YY; Hwang, JJ; Wang, HE; Tseng, YL; Pang, VF; Wang, SJ; Whang-Peng, J; Ting, G |
| 國家衛生研究院 |
2008-06 |
Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma
|
Yuan, JN; Chao, Y; Lee, WP; Li, CP; Lee, RC; Chang, FY; Yen, SH; Lee, SD; Whang-Peng, J |
| 國家衛生研究院 |
2008-01-08 |
Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial
|
Wu, CW; Chiou, JM; Ko, FS; Lo, SS; Chen, JH; Lui, WY; Whang-Peng, J |
| 國家衛生研究院 |
2008-01 |
Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy
|
Chou, KT; Chen, YM; Shih, JF; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2007-09 |
Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: Different cytogenetic changes are correlated with genders and smoking habits
|
Yen, CC; Liang, SC; Jong, YJ; Chen, YJ; Lin, CH; Chen, YM; Wu, YC; Su, WC; Huang, CYF; Tseng, SW; Whang-Peng, J |
| 國家衛生研究院 |
2007-06-01 |
Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme
|
Su, LJ; Chang, CW; Wu, YC; Chen, KC; Lin, CJ; Liang, SC; Lin, CH; Whang-Peng, J; Hsu, SL; Chen, CH; Huang, CYF |
| 國家衛生研究院 |
2007-06 |
A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naive non-small-cell lung cancer in Taiwan
|
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2007-05 |
Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy
|
Chen, YM;Liu, JM;Chou, TY;Perng, RP;Tsai, CM;Whang-Peng, J |
| 國家衛生研究院 |
2007-03 |
Effect of age on pulmonary metastases and immunotherapy in young and middle-aged mice
|
Chen, YM;Wang, PS;Liu, JM;Hsieh, YL;Tsai, CM;Perng, RP;Whang-Peng, J |
| 國家衛生研究院 |
2007-02-01 |
Monitoring and quantitative assessment of tumor burden using in vivo bioluminescence imaging
|
Chen, CC; Hwang, JJ; Ting, G; Tseng, YL; Wang, SJ; Whang-Peng, J |
| 國家衛生研究院 |
2007-02 |
Renal cell carcinoma with t(X;17)(p11.2;q25) in a 6-year-old Taiwanese boy
|
Chen, CK; Hsueh, C; Lai, JY; Hung, IJ; Whang-Peng, J; Wang, WP; Lai, HY; Chen, JR |
| 國家衛生研究院 |
2006-12-20 |
Therapeutic efficacy evaluation of 111in-VNB-liposome on human colorectal adenocarcinoma HT-29/luc mouse xenografts
|
Lee, WC; Hwang, JJ; Tseng, YL; Wang, HE; Chang, YF; Lu, YC; Ting, G; Whang-Peng, J; Wang, SJ |
| 國家衛生研究院 |
2006-12-20 |
Internal radiotherapy and dosimetric study for In-111/Lu-177-pegylated liposomes conjugates in tumor-bearing mice
|
Wang, HE; Yu, HM; Lu, YC; Heish, NN; Tseng, YL; Huang, KL; Chuang, KT; Chen, CH; Hwang, JJ; Lin, WJ; Wang, SJ; Ting, G; Whang-Peng, J; Deng, WP |
| 國家衛生研究院 |
2006-11 |
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma
|
Shiah, HS; Chao, Y; Chen, LT; Yao, TJ; Huang, JD; Chang, JY; Chen, PJ; Chuang, TR; Chin, YH; Whang-Peng, J; Liu, TW |
| 國家衛生研究院 |
2006-10-01 |
Identification of alpha-enolase as an autoantigen in lung cancer: Its overexpression is associated with clinical outcomes
|
Chang, GC; Liu, KJ; Hsieh, CL; Hu, TS; Charoenfuprasert, S; Liu, HK; Luh, KT; Hsu, LH; Wu, CW; Ting, CC; Chen, CY; Chen, KC; Yang, TY; Chou, TY; Wang, WH; Whang-Peng, J; Shih, NY |
| 國家衛生研究院 |
2006-07 |
Salvage therapy for Chinese non-small cell lung cancer patients who failed previous chemotherapy
|
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-06 |
A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy
|
Chen, YM; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-05 |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang, HJ; Wang, CC; Cheng, AL; Hsu, C; Lu, YS; Chang, MC; Lin, JT; Wang, HP; Shiah, HS; Liu, TW; Chang, JY; Whang-Peng, J; Chen, LT |
| 國家衛生研究院 |
2006-04 |
Nodal dissection for patients with gastric cancer: a randomised controlled trial
|
Wu, CW; Hsiung, CA; Lo, SS; Hsieh, MC; Chen, JH; Li, AFY; Lui, WY; Whang-Peng, J |
| 國家衛生研究院 |
2006-04 |
A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy
|
Chen, YM; Shih, JF; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-04 |
Erlotinib completely reverses topotecan-resistance in multidrug resistant cancer cells overexpressing breast cancer resistant protein 1
|
Yang, CH;Yang, CS;Huang, CJ;Cheng, AL;Whang-Peng, J;Yang, PC |
| 國家衛生研究院 |
2006-04 |
Topoisomerase 2 alpha plays a pivotal role in the tumor biology of advanced thymic neoplasia
|
Liu, JM;Hwang, BS;Wang, LS;Huang, MH;Yen, SH;Li, A;Tiu, CM;Whang-Peng, J |
| 國家衛生研究院 |
2006-03 |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah, HS; Cheng, AL; Hsu, C; Hsu, CH; Liu, TW; Chang, JY; Jan, CM; Chao, Y; Yu, WL; Chuang, TR; Whang-Peng, J; Chen, LT |
顯示項目 101-125 / 215 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
|
